Cocrystals are one of the many innovative ways that SSCI uses to solve the solid-state chemistry problems that arise during drug development to create valuable intellectual property for our clients
West Lafayette, IN (PRWEB)
November 30, 2016
SSCI, the established leader in small-molecule cocrystal technology and development, will again bring together industry experts to discuss the implications of the latest FDA guidance on pharmaceutical cocrystals as drug substance. The Lunch and Learn will take place on December 8, 2016 in Cambridge, MA.
The event follows the successful November 15th event that took place in Burlingame, CA. Eyal H. Barash, JD of Barash Law, LLC and Chief Patent Counsel to…